Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Death effector domain containing protein 2 (DEDD2) is a nuclear-localized protein characterized by the presence of a death effector domain (DED), which is a protein interaction motif crucial for regulating apoptosis and other cellular signaling pathways[3][4]. DEDD2 may regulate the trafficking of caspases—especially CASP8 and CASP10—and other proteins into the nucleus during death receptor-induced apoptosis, as well as contribute to the degradation of intermediate filaments and repression of polymerase II-dependent transcription[3][1]. As a homolog of DEDD, DEDD2 has about 48.5% sequence identity with DEDD and can interact with c-FLIP (an apoptosis regulator), DEDD, and is reported to play a critical role in the repression of gene transcription during apoptosis[1][3]. Disease relevance includes an association with colorectal adenocarcinoma[3]. DEDD2 is one of several human proteins containing DEDs, a family of apoptosis and signal transduction regulators essential for embryonic development and immune homeostasis[4]. No specific drugs, biomarkers for patient selection, or safety concerns have been described in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Death effector domain containing protein 2 (DEDD2).